A federal ruling invalidating human gene patents by Myriad Genetics (MYGN -5.4%) may have...

|About: Myriad Genetics, Inc. (MYGN)|By:, SA News Editor

A federal ruling invalidating human gene patents by Myriad Genetics (MYGN -5.4%) may have far-reaching effects; if upheld, it could shake multibillion-dollar industries built on the intellectual property rights granted by the patents taken out on 20% of human genes.